Skip to Content

Clinical Trials Details

CTSU ECOG E1609

Patient Information

CTSU ECOG E1609 - A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-risk Melanoma

View more information on clinical trial - CTSU ECOG E1609

Study Number
CTSU ECOG E1609

Clinical Trial Categories

  • Melanoma - Adjuvant

Location

  • Cone Health Cancer Center at Wesley Long
    501 N. Elam Avenue
    Greensboro, NC 27403
    Main: 336-832-1100

Also in this Section